Rapid Diagnostics Key to Ebola Response as BioFire Expands Testing in Central Africa

Accurate, rapid diagnostics capable of distinguishing Ebola from other febrile illnesses are essential to controlling the ongoing Bundibugyo Ebola outbreak, with BioFire Defense deploying its Global Fever Special Pathogens Panel to affected regions in partnership with local governments. Chuck Cooper, MD, chief medical officer at bioMérieux, offers some insights on this testing platform.